With increasing age, the risk of changes in the small blood vessels and kidney function rises. Albumin in the urine (microalbuminuria) is an early marker of such vascular and kidney damage, often associated with conditions like hypertension, diabetes, or cardiovascular disease.
In younger, healthy individuals, the likelihood of relevant abnormalities is very low, which is why the test usually provides limited additional value in this group. From around the age of 50, however, its clinical relevance increases significantly, allowing early detection of risks and enabling targeted preventive or therapeutic measures.
Need help? 💬
If you have any questions, feel free to contact us:
💬 Chatbot – Available on our website
📧 Email: [email protected]